GlassScriptPhysician profile
Lateef O Giwa
NPI 1427163120
$1,775.03
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $375 · 2021: $230 · 2022: $445 · 2023: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $538.96 | 2019-2023 | Xarelto |
| Akcea Therapeutics, INC. | $361.96 | 2019-2021 | |
| Sobi, INC | $131.15 | 2022 | |
| Novo Nordisk INC | $85.47 | 2020 | |
| Sanofi-Aventis U.S. LLC | $84.71 | 2019-2022 | |
| Amgen INC. | $82.59 | 2019-2023 | Repatha |
| Pfizer INC. | $72.60 | 2021-2022 | |
| Global Blood Therapeutics, INC. | $59.06 | 2020 | |
| Arbor Pharmaceuticals, INC. | $49.31 | 2019 | |
| Boston Scientific Corporation | $43.83 | 2022-2023 | Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $40.89 | 2019 | |
| Medtronic, INC. | $38.40 | 2022 | |
| Lilly USA, LLC | $33.85 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $30.83 | 2019 | |
| Biocompatibles, INC. | $24.05 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $21.83 | 2023 | Amvuttra |
| Bayer Healthcare Pharmaceuticals INC. | $21.35 | 2022 | |
| Merck Sharp & Dohme LLC | $21.04 | 2020 | |
| Mannkind Corporation | $16.69 | 2022 | |
| Amarin Pharma, INC. | $16.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lateef Giwa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.